Press release
Global Pulmonary Arterial Hypertension Market Size
Global Pulmonary Arterial Hypertension Market Size
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on "Global Pulmonary Arterial Hypertension Market- Forecast to 2027'' https://www.globalmarketestimates.com/market-report/pulmonary-arterial-hypertension-market-3787
By Drug Class (Endothelin Receptor Antagonists (ERAs), PDE - 5 Inhibitors, Prostacyclin and Prostacyclin Analogs, and SGC Stimulators), By Type (Branded and Generics), By Route of Administration (Oral, Intravenous/ subcutaneous and Inhalational), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
• As per the type outlook, the generics segment is expected to be the largest segment in the Pulmonary Arterial Hypertension market from 2022 to 2027
• The Asia Pacific region is analyzed to be the fastest-growing segment in the market
• As per the drug class outlook, the prostacyclin and prostacyclin analogs segment is expected to be the largest segment in the Pulmonary Arterial Hypertension market from 2022 to 2027
• North America (the United States, Canada, and Mexico) will have a dominant share in the global pulmonary arterial hypertension market from 2022 to 2027
• United Therapeutics Corporation, Bayer, Gilead Sciences, Inc., Johnson & Johnson, Viatris Inc., GlaxoSmithKline, Sandoz Inc. (Novartis), Lupin Pharmaceuticals, Inc., Sun Pharmaceutical Industries, Inc., and Teva Pharmaceutical Industries Ltd, among others, are the key players in the pulmonary arterial hypertension market.
Drug Class Outlook (Revenue, USD Billion, 2022-2027)
• Endothelin Receptor Antagonists (ERAs)
• PDE - 5 Inhibitors
• Prostacyclin and Prostacyclin Analogs
• SGC Stimulators
Type Outlook (Revenue, USD Billion, 2022-2027)
• Branded
• Generics
Route of Administration Outlook (Revenue, USD Billion, 2022-2027)
• Oral
• Intravenous/ subcutaneous
• Inhalational
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA
Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pulmonary Arterial Hypertension Market Size here
News-ID: 2619697 • Views: 559
More Releases from Global Market Estimates Research & Consultants
Global Architectural Coatings Market Size & Trends
According to a new market research report published by Global Market Estimates, the global architectural coatings market is expected to grow at a CAGR of 5.6% from 2023 to 2028.
The global architectural coatings market growth is driven by the flourishing construction industry, urbanization, and rising demand for commercial and residential spaces due to the increasing population.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth…
Global Maritime Surveillance Market Size & Trends
According to a new market research report published by Global Market Estimates, the global maritime surveillance market is expected to grow at a CAGR of 9.6% from 2023 to 2028.
Global maritime surveillance market growth is driven by rising concerns for the safety and security of expanding maritime trade.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on "Global Maritime Surveillance Market - Forecast to…
Global ENT Devices Market Size & Trends
According to a new market research report published by Global Market Estimates, the global ENT devices market is projected to grow at a CAGR of 6.8% from 2023 to 2028.
The growth of the global ENT devices market is driven by increasing prevalence of ENT disorders, increasing aging population, advancements in medical technology expanding ENT treatment options, and rising focus on personalized and patient-centric care including implants and hearing aids, contributes…
Global Hydrogen Fluoride Gas Detection Market Size & Trends
According to a new market research report published by Global Market Estimates, the global hydrogen fluoride gas detection market is projected to grow at a CAGR of 5.4% from 2023 to 2028.
The growth of the global hydrogen fluoride gas detection market is driven by increasing regulation and safety standards, growing environmental awareness, continuous innovation in sensor technology and detection systems, increasing accidents related to hydrogen fluoride gas, and growing awareness…
More Releases for Pulmonary
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape.
Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood…
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot
The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
Europe Pulmonary Drugs Market grows with incredible awareness about the treatmen …
The intensity of competition in the global pulmonary drugs market is exceptionally high with the presence of few dominant players. However, Transparency Market Research observes that the leading players are expected to lose their share in the overall market as patents for several drugs are poised to expire in the coming years. The top five players in the market are GlaxoSmithKline Plc., Boehringer Ingelheim GmbH, Astra Zeneca, Teva Pharmaceutical Industries…
